Leerink Partners Adjusts Price Target on Boston Scientific to $55 From $60

MT newswire2026/10/09 13:41

09:41 AM EDT, 10/09/2026 (MT Newswires) -- Boston Scientific (BSX) has an average rating of overweight and mean price target of $58.61, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us) Price: 42.06, Change: +0.04, Percent Change: +0.08

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

BUZZ-Preview: NextEra Energy is expected to report both revenue and earnings per share growth in its financial results to be released on Wednesday.

路透社•2026/10/20 19:41

Updated version 1 - Kroger plans to invest $5 billion by 2029, the new CEO will further focus on the grocery business.

路透社•2026/10/20 19:36

Strategy tokenized stock chain listed value reaches $473 millions

AiCoin•2026/10/20 19:27

Forex Today: UK inflation comes to the fore

FXStreet•2026/10/20 19:12